Steve Butcher

Operating Partner

Steve joined Advent in 2015, and brings 20 years of executive leadership experience in both small biotech and larger pharmaceutical companies in the UK, Japan, and Scandinavia. He has a strong track record of R&D expertise in pre-clinical drug discovery as well as business development and corporate responsibilities. Steve was most recently COO of Coco Therapeutics and prior to that, COO and VP Corporate Development at Topotarget A/S in Copenhagen.

Steve is originally a pharmacologist with a PhD from the University of Southampton.

Steve plays a key role in Advent’s diligence into pre-clinical small molecule programs, and has been an advisor to several investee companies including Artax.

Assistant: Amber Rosamond
E: This email address is being protected from spambots. You need JavaScript enabled to view it.
T: +44 (0)20 7932 2157

Back